Abstract
The 5-HT7 receptor (5-HT7R), characterized in 1993, is the most recently described member of the serotonin family. Since its discovery, 5-HT7R has been the subject of extensive research due to its widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to illustrate the literature concerning developments of the last few years (2007-2010) towards the discovery of novel and selective 5-HT7R ligands, agonists, antagonist and inverse agonists.
Keywords: 5-HT7R, 5-HT7 ligands, agonists, antagonists, G protein-coupled receptors, serotonin, serotonin receptor subtypes, CNS, PNS, GPCRs
Mini-Reviews in Medicinal Chemistry
Title: Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands
Volume: 11 Issue: 13
Author(s): V. Pittala and D. Pittala
Affiliation:
Keywords: 5-HT7R, 5-HT7 ligands, agonists, antagonists, G protein-coupled receptors, serotonin, serotonin receptor subtypes, CNS, PNS, GPCRs
Abstract: The 5-HT7 receptor (5-HT7R), characterized in 1993, is the most recently described member of the serotonin family. Since its discovery, 5-HT7R has been the subject of extensive research due to its widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to illustrate the literature concerning developments of the last few years (2007-2010) towards the discovery of novel and selective 5-HT7R ligands, agonists, antagonist and inverse agonists.
Export Options
About this article
Cite this article as:
Pittala V. and Pittala D., Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands, Mini-Reviews in Medicinal Chemistry 2011; 11 (13) . https://dx.doi.org/10.2174/138955711797655353
DOI https://dx.doi.org/10.2174/138955711797655353 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies
Current Neuropharmacology A Role of GABA Analogues in the Treatment of Neurological Diseases
Current Medicinal Chemistry Is There Any Scientific Basis of Hawan to be Used in the Alzheimer’s Disease Prevention/Cure?
Current Traditional Medicine Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis
Current Signal Transduction Therapy Shilajit (Mumie): Current Status of Biochemical, Therapeutic and Clinical Advances
Current Nutrition & Food Science Approaching Inherited Disease on a Genomic Scale
Current Genomics A Concise Review on Multidimensional Silver Nanoparticle Health Aids and Threats
Current Drug Therapy The Muscular Dystrophies Associated with Central Nervous System Lesions: A Brief Review from a Standpoint of the Localization and Function of Causative Genes
Current Pediatric Reviews Animal Venom Peptides: Potential for New Antimicrobial Agents
Current Topics in Medicinal Chemistry GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Current Neuropharmacology Developing Pharmacotherapies for Cannabis and Cocaine Use Disorders
Current Neuropharmacology Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?
CNS & Neurological Disorders - Drug Targets Animal Models of Narcolepsy
CNS & Neurological Disorders - Drug Targets Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties
Current Alzheimer Research Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders
Current Medicinal Chemistry Structural Properties of the NMDA Receptor and the Design of Neuroprotective Therapies
Mini-Reviews in Medicinal Chemistry Synthesis and Antioxidant Activity of Indole Derivatives Containing 4-Substituted Piperazine Moieties
Letters in Drug Design & Discovery Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Editorial
Current Pediatric Reviews